SIGA Technologies Inc (NASDAQ:SIGA)

Data as of Oct 22
 -0.04 / -2.74%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

SIGA Technologies, Inc. operates as a company specializing in the development and commercialization of solutions for serious unmet medical needs and bio threats. The company specializes in developing therapeutic solutions for some of the most lethal pathogens, which include smallpox, Ebola, dengue, Lassa fever and other dangerous viruses. Its product Arestvyr also known as ST-246, is an orally administered antiviral drug that targets orthopoxviruses. SIGA Technologies was founded on December 28, 1995 and is headquartered in New York, NY.

Contact Information

SIGA Technologies, Inc.
660 Madison Avenue
New York New York 10065
P:(212) 672-9100
Investor Relations:



Individual stakeholders33.43%
Other institutional25.89%
Mutual fund holders2.37%

Top Executives

Eric A. RoseChairman & Chief Executive Officer
Daniel J. LuckshireChief Financial Officer, Secretary & Executive VP
Dennis E. HrubyChief Scientific Officer & Vice President
William J. HaynesExecutive Vice President & General Counsel

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.